The present invention relates to a novel method for dosing sterile syringes and to a device for use with said method, which confers significant advantages compared with that known in the present state of the art.
In particular, the present invention relates to a method for dosing sterile syringes that can be applied to medicinal products which provides a guarantee of sterility when dosing. More specifically, the present invention applies to a novel method of reducing exposure of the inside of the syringes to particulate pollutants and thus ensuring sterile dosing of the syringes.
Automated syringe dosing methods and systems with a wide variety of characteristics are known in the prior art. Dosing systems exist in the prior art which comprise a dosing area in which said dosing is carried out using a robotic arm which handles a number of dispensing units. Said dosing systems dose the syringes either individually or in a group under sterile conditions and usually while subjecting said syringes to a vertical laminar flow. This means that the laminar airflow coming from the area above the system is partly impeded by the dispensing system, causing turbulence in the flow that reaches the syringes and significantly reducing the protection said flow would provide under laminar conditions. Moreover, said dosing systems do not usually envisage protecting the open end of the syringes by a physical barrier, which results in a risk of contamination by suspended particulates.
Furthermore, syringe dosing methods and the corresponding systems wherein dosing is carried out individually are known in the prior art.
In a first aspect, the present invention relates to a method for dosing sterile syringes with medicinal products which includes: (a) arranging a group of syringes in a syringe nest and the syringe nest in turn in a device, the device comprising a cover; (b) sterilizing the syringes thus arranged, the sterilization being performed by a thermal process; (c) loading the devices with the sterile syringes in a dispensing system in order to dose the syringes; (d) uncovering, dosing and covering the syringes using a dosing system in the presence of a laminar flow, where the device allows sterilization of the nests and protects the inside of the syringes from suspended particulates by means of the cover, which acts as a physical barrier. In some embodiments, the sterilization is carried out in an autoclave with steam. In some embodiments, cooling step is carried out in a sterile area of the autoclave. In some embodiments, the syringes are uncovered by removing the cover from the device.
In some embodiments, the uncovering, dosing and covering step is carried out in a dosing area which is in the presence of a laminar flow, where the laminar flow is a horizontal laminar flow, the devices being arranged in such a way that a base of the device is parallel to the horizontal laminar flow, so that the longitudinal axis of the syringes is substantially vertical and the open end thereof is facing upwards.
In some embodiments, the uncovering, dosing and covering step is carried out under class II, type A conditions (DIN EN 12469:2000-09).
In some embodiments, a device for dosing sterile syringes according to the method described above includes: a substantially prism-shaped structure in which at least an upper face is an open face which defines a perimeter area relative to the open face, the perimeter area having a vertical peripheral surface, the structure also comprising lateral surfaces with upper ends close to the open upper face and lower ends close to a base, the structure being arranged so as to allow the syringe nests to be inserted through at least said open upper face and a cover which, in the closed position, rests on the perimeter area of the open upper face of the device, the cover being arranged so as to cover the syringes.
In some embodiments, a device for receiving syringe nests in order to carry out the method for dosing sterile syringes described above includes a substantially prism-shaped structure in which at least an upper face is an open face which defines a perimeter area relative to the open face, a vertical peripheral surface being arranged on the perimeter area, the structure also include lateral surfaces with upper ends close to the open upper face and lower ends close to a base, the structure being arranged so as to allow the syringe nests to be inserted through at least said open upper face and a cover which, in the closed position, rests on the perimeter area of the open upper face of the device, the cover being arranged so as to cover the syringes. In some embodiments, the device further includes an edge on the perimeter area of the open upper face on which a peripheral portion of the syringe nest rests and support surfaces arranged between the lateral surfaces, so that said inner edge and said support surfaces distribute the load applied by the syringes to the device, thus reducing the stresses to which the syringe nest is subjected.
In some embodiments, the cover of the device includes protrusions which project towards the inside of the device, encircling the open ends of the syringes. In some embodiments, the cover of the device includes a skirt arranged around the perimeter thereof, encircling the device and contacting the vertical peripheral surface of the device by means of a peripheral protrusion.
In some embodiments, the cover of the device comprises fastening means to act on the device. In some embodiments, the fastening means are dimensional interference fastening means. In some embodiments, the structure of the device includes reception means for receiving the means for fastening the cover.
These and other advantages and characteristics of the invention will be made clear in view of the figures and the detailed description of the invention. Said figures should be understood as an explanatory but non-limiting example of an embodiment of the dosing system according to the present invention.
An object of the present invention is to disclose a dosing method and a device for carrying out said method which allows the entire syringe dosing method to be carried out safely, from sterilisation in an autoclave to dosing and covering the syringes, limiting the time the syringes are exposed to suspended particulates, said method also being effective.
To attain this object, a method for dosing sterile syringes with medicinal products is used which comprises the following steps:
wherein said device allows sterilisation of the syringes and protects the inside of the syringes from suspended particulates by means of the cover, which acts as a physical barrier.
The device according to the present invention allows sterilisation to take place without the syringe nests suffering significant deformations, preferably by providing said syringe nests with a support, and at the same time preferably has means for protecting the interior of the syringes.
Preferably, the thermal process may be sterilisation with steam in an autoclave. Other thermal processes are also possible, such as sterilisation by delivering air or another gas with controlled temperature properties.
Preferably, the syringes are sterilised in an autoclave with saturated steam.
Preferably, the syringe cooling step is carried out in a sterile area of the autoclave where the presence of a laminar flow is not necessary. This cooling step may be carried out by supplying clean process air/filtered air, the flow and/or temperature of which can be controlled over time. This process is usually referred to as “tempering”. If desired, the density and/or pressure conditions may also be controlled to minimise the risk of air entering, this step being carried out in an area of maximum environmental control and quality.
More preferably, the syringes are uncapped by removing the cover from the device. This allows the syringe dosing method to be much more efficient than alternatives such as uncovering the syringes individually.
More preferably, the syringes are capped individually after being dosed.
Still more preferably, the syringe dosing method also has a step of weighing at least one of the dosed syringes. Said weighing step allows the calibration of the dosing system to be checked.
Still more preferably, the step of loading the devices in the dispensing system is performed automatically using automatic distribution means such as robotic arms and/or conveyor belts. However, the loading step may also be carried out manually by qualified technicians or semi-automatically.
Advantageously, the syringe uncovering, dosing and covering step is carried out in a dosing area which is subjected to a horizontal laminar flow, the devices being arranged with a base thereof parallel to the horizontal laminar flow so that the longitudinal axis of the syringes is substantially vertical and the open end thereof is facing upwards.
More advantageously, the syringe uncovering, dosing and covering step is carried out in an environment under class II, type A conditions (DIN EN 12469:2000-09). These conditions protect the operators in the vicinity from the products being handled, and the medicinal products from contamination by the external environment.
Still more advantageously, during the syringe dosing, the device is arranged so that the horizontal laminar flow is not impeded or obstructed at least until reaching an open end of the syringes. This is particularly advantageous when the syringes are subject to a horizontal laminar flow, as the laminar flow can be maintained, significantly reducing the presence of turbulence in the vicinity of the open ends of the syringes.
In addition, preferably, the device for the method described above comprises:
In addition, the present invention also discloses a device for receiving syringe nests which comprises:
The inside of the structure of the device may also communicate with the outside through the lateral surfaces and/or base thereof, so that steam from the autoclave can access the syringe nests arranged in the device at multiple points from the outside via said open surfaces. In addition, the cover is a physical barrier and significantly reduces the risk of suspended particulates penetrating the interior of the syringes.
Preferably, the device also comprises an edge on the perimeter area of the open upper face on which a peripheral portion of the syringe nest rests and syringe nest support surfaces arranged between the lateral surfaces of the device.
Both the edge and the support surfaces act as contact areas between the syringe nest and the device and distribute the load applied by the syringes to the device, thus reducing the stresses to which the syringe nest is subjected.
More preferably, the cover of the device is independent of the device, in other words, the cover and the device are not mechanically connected.
Still more preferably, the cover of the device comprises protrusions which project towards the inside of the device, encircling the open ends of the syringes. Equally preferably, the cover of the device comprises a skirt arranged around the perimeter thereof, encircling the device around the perimeter thereof and in turn contacting a vertical surface arranged on the perimeter area of the open upper face by means of a peripheral protrusion. Advantageously, the cover may comprise fastening means to act on the device, said fastening means being advantageously dimensional interference means. However, the fastening means may also comprise magnetic and/or resilient elements to facilitate the closing or opening of the cover.
Said cover arrangements on the devices create labyrinthine communication between the outside and the inside of the syringes, which is particularly advantageous when protecting the inside of the syringes from suspended particulates.
Said reception means may comprise indentations, tapers, shaped profiles or other reception means known in the prior art.
Preferably, the device is made of a material that is resistant both to high temperatures (up to at least 150° C.) and high temperature gradients. Said material may be stainless steel, metal alloys or other known materials.
The use of said devices facilitates handling of the syringe nests given that said syringe nests, on being subjected to high temperatures during the sterilisation step, tend to deform owing to the weight of the syringes. However, when syringe nests are arranged in the devices according to the present invention, the syringe nests transfer the load or weight of the syringes to said devices, thus preventing deformation of the syringe nests. This is particularly advantageous when carrying out the subsequent steps of the method, since preventing deformation of the syringe nests facilitates the dosing thereof. Indeed, any severe deformations the syringe nest might suffer would in particular make it significantly difficult to handle said syringe nest, which would in turn affect the correct distribution and alignment of the syringes, possibly making dosing of the syringes impossible.
Preferably, in the method for dosing sterile syringes according to the present invention, the device is a device as described above.
The term “dosing” refers to partly or completely filling the syringe with a predetermined amount. The term “syringe nest” refers to a physical support in which a group of syringes may be arranged individually. The terms “lower”, “upper” and “lateral” refer to a relative arrangement between the components on which they are associated; said terms should not be understood as a limitation with regard to the arrangement of said components with respect to the general orientation of the dosing system. The terms “horizontal” and “vertical” refer to an arrangement substantially parallel to the ground and parallel to the direction of gravitational attraction, respectively, said orientations being substantially perpendicular.
A syringe dosing method according to the present invention will be described in detail below.
The sterile syringe dosing method of
Next, said units made up of the syringes 1, the syringe nests 2 and the devices 3, and more specifically the syringes 1, are subjected to cooling 8. Said cooling is preferably carried out in the autoclave. Optionally, this step may take place in a filtered laminar airflow 9 of class II, type A (DIN EN 12469:2000-09), produced by known ventilation means 10, minimising the risk of air entering when the syringes are cooled by a reduction in air density, said filtered laminar airflow 9 forming a basically one-directional refrigeration circuit from entry to the apparatus 10 to exit from the sterile area of the autoclave.
The next step in the method relates to the delivery 11 of the units made up of the syringes 1, the syringe nests 2 and the devices 3 to a dosing system. Said delivery 11 may be carried out automatically using known delivery means such as robotic arms or conveyor belts, among others. Moreover, delivery 11 may be effected with the supervision and/or collaboration of qualified technical staff, semi-automatically or manually.
Next, the syringe uncovering, dosing and covering step 12 is carried out in a dosing area where the devices 3 are uncovered to allow the dosing system to access the syringes 1 and carry out the dosing 12. Once dosing is complete, the syringes are capped. These operations are carried out in a dosing area under a filtered laminar airflow, preferably under class II, type A conditions (DIN EN 12469:2000-09), and subjected to a horizontal laminar flow 13 produced by known ventilation means 10. Moreover, as explained above, the arrangement of the devices 3 relative to said horizontal laminar flow 13 is such as to ensure the horizontal laminar flow 13 does not encounter any obstacle or obstruction before reaching the open end of the syringes 1. This arrangement prevents turbulence from being produced in the vicinity of the open ends of the syringes 1, reducing the possibility of suspended particulates contaminating said syringes.
In addition, during or after dosing, one or more dosed syringes may be weighed to check that the dosing system is correctly calibrated.
Moreover,
In addition, the device 3 shown comprises a vertical surface 36 arranged on the perimeter area of the open upper face 37. This vertical surface 36 facilitates adjustment between the device 33 and the cover 300 thereof (not shown in the present figure). Said arrangement can be clearly seen in
In addition, the cover 300 may also comprise protrusions 302 which project towards the inside of the device 3, encircling the perimeter of the open end 10 of the syringes and creating labyrinthine communication between the outside and the inside of the syringes 1.
Accordingly, when the cover 300 is positioned on the device 3, a suspended particulate outside the device 3 will be prevented from accessing the inside of the syringes 1.
Although the invention has been described with respect to a preferred embodiment, this should not be deemed to limit the invention, and it is possible to change structural or other details which may be obvious to a person skilled in the art after interpreting the subject matter disclosed in the present description, claims and drawings. In particular, in principle and unless explicitly stated, all the characteristics of the different embodiments and alternatives shown and/or suggested may be combined. Therefore, the protection of the present invention includes any variant or equivalent that could be considered covered by the widest interpretation of the following claims.
Number | Date | Country | Kind |
---|---|---|---|
21382654.8 | Jul 2021 | EP | regional |
This application is the U.S. National Phase Application under 35 U.S.C. § 371 of International Application No. PCT/ES2022/070465, filed Aug. 18, 2022, designating the U.S. and published as WO 2023/002078 A1 on Jan. 26, 2023, which claims the benefit of Provisional Application No. 21/382,654.8, filed Aug. 19, 2021. Any and all applications for which a foreign or a domestic priority is claimed is/are identified in the Application Data Sheet filed herewith and is/are hereby incorporated by reference in their entireties under 37 C.F.R. § 1.57.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/ES2022/070465 | 7/18/2022 | WO |